HUP0600331A2 - Farnesyltransferase inhibitors - Google Patents
Farnesyltransferase inhibitorsInfo
- Publication number
- HUP0600331A2 HUP0600331A2 HU0600331A HUP0600331A HUP0600331A2 HU P0600331 A2 HUP0600331 A2 HU P0600331A2 HU 0600331 A HU0600331 A HU 0600331A HU P0600331 A HUP0600331 A HU P0600331A HU P0600331 A2 HUP0600331 A2 HU P0600331A2
- Authority
- HU
- Hungary
- Prior art keywords
- farnesyltransferase inhibitors
- farnesyltransferase
- inhibitors
- Prior art date
Links
- 239000003528 protein farnesyltransferase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72723000A | 2000-11-30 | 2000-11-30 | |
| US09/912,677 US20020115640A1 (en) | 2000-11-30 | 2001-07-25 | Farnesyltransferase inhibitors |
| PCT/US2001/043168 WO2002074747A1 (en) | 2000-11-30 | 2001-11-30 | Farnesyltransferase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0600331A2 true HUP0600331A2 (en) | 2006-10-28 |
Family
ID=24921844
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0600331A HUP0600331A2 (en) | 2000-11-30 | 2001-11-30 | Farnesyltransferase inhibitors |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US20020115640A1 (hu) |
| EP (1) | EP1339695B1 (hu) |
| JP (1) | JP2004519503A (hu) |
| KR (1) | KR20030060968A (hu) |
| CN (1) | CN1487924A (hu) |
| AR (1) | AR035375A1 (hu) |
| AT (1) | ATE323681T1 (hu) |
| BG (1) | BG107908A (hu) |
| BR (1) | BR0112028A (hu) |
| CA (1) | CA2430619A1 (hu) |
| CY (1) | CY1106104T1 (hu) |
| CZ (1) | CZ20031804A3 (hu) |
| DE (1) | DE60118955T2 (hu) |
| DK (1) | DK1339695T3 (hu) |
| EC (1) | ECSP034634A (hu) |
| ES (1) | ES2261340T3 (hu) |
| HK (1) | HK1059260A1 (hu) |
| HU (1) | HUP0600331A2 (hu) |
| IL (2) | IL156212A0 (hu) |
| MX (1) | MXPA03004879A (hu) |
| MY (1) | MY136181A (hu) |
| NO (1) | NO20032471L (hu) |
| NZ (1) | NZ526313A (hu) |
| PE (1) | PE20020687A1 (hu) |
| PL (1) | PL363637A1 (hu) |
| PT (1) | PT1339695E (hu) |
| SA (1) | SA01220565B1 (hu) |
| SI (1) | SI1339695T1 (hu) |
| SK (1) | SK286686B6 (hu) |
| UY (1) | UY27046A1 (hu) |
| WO (1) | WO2002074747A1 (hu) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006116716A2 (en) * | 2005-04-27 | 2006-11-02 | University Of Florida | Materials and methods for enhanced degradation of mutant proteins associated with human disease |
| JP4592548B2 (ja) * | 2005-08-24 | 2010-12-01 | 株式会社エヌ・ティ・ティ・ドコモ | 送信電力制御方法及び移動通信システム |
| US7722316B2 (en) * | 2005-09-13 | 2010-05-25 | Rolls-Royce Power Engineering Plc | Acoustic viscous damper for centrifugal gas compressor |
| US7790770B2 (en) | 2005-11-23 | 2010-09-07 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| TW200806284A (en) * | 2006-03-31 | 2008-02-01 | Alcon Mfg Ltd | Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma |
| US8084477B2 (en) * | 2007-10-31 | 2011-12-27 | Bristol-Myers Squibb Company | Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production |
| EP2315751A1 (en) * | 2008-06-26 | 2011-05-04 | Amgen Inc. | Alkynyl alcohols as kinase inhibitors |
| US20130324521A1 (en) * | 2010-11-26 | 2013-12-05 | Reza Ghotbi | Implant for treating or preventing an aneurysm |
| CN105693617B (zh) * | 2014-11-24 | 2018-06-08 | 中国科学院大连化学物理研究所 | 一种tmsn3参与的还原环化反应制备4-咪唑甲醛衍生物的方法 |
| WO2017062552A1 (en) | 2015-10-07 | 2017-04-13 | Tc1 Llc | Resonant power transfer systems having efficiency optimization based on receiver impedance |
| CN112851508A (zh) * | 2019-11-27 | 2021-05-28 | 广东东阳光药业有限公司 | 一种巴洛沙韦中间体的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997036901A1 (en) * | 1996-04-03 | 1997-10-09 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US6297239B1 (en) * | 1997-10-08 | 2001-10-02 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
| EP1107962B1 (en) * | 1998-08-27 | 2005-02-23 | Pfizer Products Inc. | Quinolin-2-one derivatives useful as anticancer agents |
-
2001
- 2001-07-25 US US09/912,677 patent/US20020115640A1/en not_active Abandoned
- 2001-10-24 MY MYPI20014939A patent/MY136181A/en unknown
- 2001-11-29 UY UY27046A patent/UY27046A1/es not_active Application Discontinuation
- 2001-11-29 PE PE2001001198A patent/PE20020687A1/es not_active Application Discontinuation
- 2001-11-29 AR ARP010105568A patent/AR035375A1/es unknown
- 2001-11-30 DK DK01273519T patent/DK1339695T3/da active
- 2001-11-30 NZ NZ526313A patent/NZ526313A/en unknown
- 2001-11-30 ES ES01273519T patent/ES2261340T3/es not_active Expired - Lifetime
- 2001-11-30 MX MXPA03004879A patent/MXPA03004879A/es active IP Right Grant
- 2001-11-30 PL PL01363637A patent/PL363637A1/xx not_active Application Discontinuation
- 2001-11-30 KR KR10-2003-7007345A patent/KR20030060968A/ko not_active Application Discontinuation
- 2001-11-30 CN CNA018223427A patent/CN1487924A/zh active Pending
- 2001-11-30 JP JP2002573756A patent/JP2004519503A/ja active Pending
- 2001-11-30 EP EP01273519A patent/EP1339695B1/en not_active Expired - Lifetime
- 2001-11-30 HU HU0600331A patent/HUP0600331A2/hu unknown
- 2001-11-30 PT PT01273519T patent/PT1339695E/pt unknown
- 2001-11-30 AT AT01273519T patent/ATE323681T1/de not_active IP Right Cessation
- 2001-11-30 WO PCT/US2001/043168 patent/WO2002074747A1/en active IP Right Grant
- 2001-11-30 CZ CZ20031804A patent/CZ20031804A3/cs unknown
- 2001-11-30 SK SK823-2003A patent/SK286686B6/sk not_active IP Right Cessation
- 2001-11-30 BR BR0112028-0A patent/BR0112028A/pt not_active IP Right Cessation
- 2001-11-30 SI SI200130573T patent/SI1339695T1/sl unknown
- 2001-11-30 DE DE60118955T patent/DE60118955T2/de not_active Expired - Fee Related
- 2001-11-30 IL IL15621201A patent/IL156212A0/xx active IP Right Grant
- 2001-11-30 CA CA002430619A patent/CA2430619A1/en not_active Abandoned
- 2001-12-02 SA SA01220565A patent/SA01220565B1/ar unknown
-
2003
- 2003-05-29 IL IL156212A patent/IL156212A/en not_active IP Right Cessation
- 2003-05-30 EC EC2003004634A patent/ECSP034634A/es unknown
- 2003-05-30 NO NO20032471A patent/NO20032471L/no not_active Application Discontinuation
- 2003-06-13 BG BG107908A patent/BG107908A/bg unknown
-
2004
- 2004-01-27 HK HK04100551A patent/HK1059260A1/xx not_active IP Right Cessation
-
2006
- 2006-06-23 CY CY20061100852T patent/CY1106104T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1081545A1 (en) | Vla-4 inhibitors | |
| HK1061030A1 (en) | Rho-kinase inhibitors | |
| HK1061029A1 (en) | Rho-kinase inhibitors | |
| AU8212901A (en) | Deacetylase inhibitors | |
| GB9912961D0 (en) | Metalloprotease inhibitors | |
| GB9900416D0 (en) | Inhibitors | |
| AU3408801A (en) | Tnf-alpha inhibitors | |
| AU4217201A (en) | Tri-aryl-substituted-ethane pde4 inhibitors | |
| IL145085A0 (en) | Dihetero-substituted metalloprotease inhibitors | |
| HK1053833A1 (zh) | 取代苯基法呢基轉移酶抑制劑 | |
| DE60142731D1 (en) | Ation | |
| HK1040374B (zh) | 拭子 | |
| IL156212A0 (en) | Farnesyltransferase inhibitors | |
| HK1042695A1 (zh) | 蛋白酶抑制劑 | |
| GB2389113B (en) | B-secretase inhibitor | |
| HK1043078B (zh) | 清潔簽 | |
| GB0014861D0 (en) | Novel telomerase inhibitors | |
| GB0015996D0 (en) | Inhibitors | |
| GB0021193D0 (en) | Inhibitors | |
| GB0029730D0 (en) | Inhibitors | |
| GB0029733D0 (en) | Inhibitors | |
| GB0004895D0 (en) | Inhibitor | |
| GB0005017D0 (en) | Inhibitor | |
| SI1272488T1 (sl) | Tri-aril-substituirani-etan PDE4-inhibitorji | |
| GB0101135D0 (en) | Inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |